Royal Bank of Scotland Group plc posts £2bn loss. Buy or sell?

Should you buy or sell Royal Bank of Scotland Group plc (LON:RBS) after today’s results?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Royal Bank of Scotland (LSE: RBS) was today the last of the big four FTSE 100 banks to release its half-year results. And the report made for dismal reading, sending the shares down 5% in early trading.

Legacy issues

RBS posted a first-half loss of just over £2bn as legacy issues once again took their toll. We already knew the bank had made a final £1.2bn payment on the government’s dividend access share in Q1 (paving the way for ordinary dividends to resume at some point), but Q2 saw a whopping £1.3bn of further exceptional items in the familiar form of litigation and conduct costs, including further provisions for PPI and shareholder litigation relating to the 2008 rights issue.

Meanwhile, as a result of US conduct investigations, the bank said “substantial related incremental provisions may be recognised during the remainder of the year.

Other troubles

RBS took impairment charges in its oil & gas and shipping portfolios. It cautioned on “a continuing risk of large single name/sector driven events across our portfolios given the uncertain macroeconomic environment.” And it added that the Brexit vote “has increased the level of uncertainty however it is too early at this point to quantify the impact of any potential credit losses that may result.”

The company expects restructuring costs to remain high in 2016, totalling over £1bn. The H1 charge was £0.63bn, well over half of which related to Williams & Glyn, which RBS is obliged to divest. However, management has abandoned a programme to create a cloned banking platform to separate Williams & Glyn, and will “prioritise exploring alternative means to achieve divestment.”

And the good news?

I couldn’t find too many positives in the results, and most of them were followed by a big ‘but’. For example, there was decent growth in mortgages and commercial lending — but, going forward, momentum is likely to be offset by headwinds from the reduction in interchange fees, low interest rates and the uncertain macroeconomic environment.

Similarly, the company said it’s on track to achieve a £0.8bn cost reduction in 2016 — but the first-half cost-to-income ratio deteriorated markedly on the same period last year (72% versus 64%). Management said: “In the current low rate and low growth environment, achieving our longer-term cost:income ratio and return targets by 2019 is likely to be more challenging.”

Investment case

I find it hard to see there’s an investment case for RBS at this stage. The bank is still 73%-owned by the taxpayer and the resumption of dividends for shareholders looks as far away as ever. RBS has faced an uphill battle since the financial crisis, and it seems to me that the gradient of that hill, which looked like it might be starting to level off a year or two ago, has just steepened again.

The shares are currently trading around 183p, which is well down from their post-financial-crisis high of over 400p in late 2014. However, earnings downgrade has followed earnings downgrade such that the bank trades on a rich 17 times current-year forecast earnings.

I wouldn’t be surprised to see further earnings markdowns from analysts, both in the short and medium term. In which case I see the shares re-testing their post-referendum low of 149p, rather than heading north from their current level. As such, I can only rate RBS a sell, until earnings visibility improves.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

G A Chester has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Light bulb with growing tree.
Investing Articles

3 top investment trusts that ‘green’ up my Stocks and Shares ISA

I’ll be buying more of these investment trusts for my Stocks and Shares ISA given the sustainable and stable returns…

Read more »

Investing Articles

8.6% or 7.2%? Does the Legal & General or Aviva dividend look better?

The Aviva dividend tempts our writer. But so does the payout from Legal & General. Here he explains why he'd…

Read more »

a couple embrace in front of their new home
Investing Articles

Are Persimmon shares a bargain hiding in plain sight?

Persimmon shares have struggled in 2024, so far. But today's trading update suggests sentiment in the housing market's already improving.

Read more »

Market Movers

Here’s why the Unilever share price is soaring after Q1 earnings

Stephen Wright isn’t surprised to see the Unilever share price rising as the company’s Q1 results show it’s executing on…

Read more »

Investing Articles

Barclays’ share price jumps 5% on Q1 news. Will it soon be too late to buy?

The Barclays share price has been having a great time this year, as a solid Q1 gives it another boost.…

Read more »

Young black colleagues high-fiving each other at work
Investing Articles

The AstraZeneca share price lifts 5% on a top-and-bottom earnings beat

The AstraZeneca share price reached £120 today and helped push the FTSE 100 higher. Would I still buy this flying…

Read more »

Young black woman using a mobile phone in a transport facility
Market Movers

Meta stock slumps 13% after poor results. Here’s what I’ll do

Jon Smith flags up the reasons behind the fall in the Meta stock price overnight, along with his take on…

Read more »

Young Caucasian girl showing and pointing up with fingers number three against yellow background
Investing Articles

3 FTSE stocks I wouldn’t ‘Sell in May’

If the strategy had any merit in the past, I see no compelling evidence it's a smart idea today. Here…

Read more »